Sanofi eyes Zentiva in quarter-stake buyout
Looking to establish itself in Eastern Europe, French drug maker Sanofi-Aventis has bought a 24.9 per cent stake in Czech generic drug firm Zentiva for $514.7m (€430m).
Looking to establish itself in Eastern Europe, French drug maker Sanofi-Aventis has bought a 24.9 per cent stake in Czech generic drug firm Zentiva for $514.7m (€430m).
Ranbaxy has announced the purchase of Senetek's Autoinjector rights and assets for its proprietary disposable autoinjector for self-administration of parenteral drugs, adding to Ranbaxy's growing presence in the growing self-medication market.
Rapid growth in the biopharmaceutical sector in China, India and Southeast Asia has prompted US filtration specialist Pall to devote more resources and industry experts to these regions, as the 14 per cent growth seen in its BioPharm business over the...
A simple laboratory method to treat Parkinson's disease, which involves electric currents, has been developed by researchers, who believe the use of this method will reduce or eliminate the need to treat this disorder with drug therapies.
Systech and Domino Printing Sciences has announced an agreement that will combine Systech's TIPS Serialised Product Tracking methods with Domino's marking and coding technology as a solution to combat counterfeit product and increase patient safety.